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Abstract
Background: Type 2 diabetes (T2D) is a metabolic disorder characterized by disturbances of carbohydrate, fat and protein
metabolism and insulin resistance. The majority of T2D patients are obese and obesity by itself may be a cause of insulin
resistance. Our aim was to evaluate whether the recently identified T2D risk alleles are associated with human measures of
fatness as characterized with Dual Energy X-ray Absorptiometry (DEXA).
Methodology/Principal Findings: Genotypes and phenotypes of approximately 3,000 participants from cross-sectional ERF
study were analyzed. Nine single nucleotide polymorphisms (SNPs) in CDKN2AB, CDKAL1, FTO, HHEX, IGF2BP2, KCNJ11,
PPARG, SLC30A8 and TCF7L2 were genotyped. We used linear regression to study association between individual SNPs and
the combined allelic risk score with body mass index (BMI), fat mass index (FMI), fat percentage (FAT), waist circumference
(WC) and waist to hip ratio (WHR). Significant association was observed between rs8050136 (FTO) and BMI (p=0.003), FMI
(p=0.007) and WC (p=0.03); fat percentage was borderline significant (p=0.053). No other SNPs alone or combined in a risk
score demonstrated significant association to the measures of fatness.
Conclusions/Significance: From the recently identified T2D risk variants only the risk variant of the FTO gene (rs8050136)
showed statistically significant association with BMI, FMI, and WC.
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Introduction
Type 2 diabetes mellitus (T2D) is a metabolic disorder
characterized by disturbances of carbohydrate, fat and protein
metabolism and insulin resistance [1]. The effects of T2D include
long-term damage, dysfunction and failure of various organs. The
global prevalence of diabetes is currently estimated as 2.8% (171
millions patients worldwide), and this figure projects to at least
4.4% (366 millions) at year 2030 [2].
The majority of T2D patients are obese and obesity by itself
may be a cause of insulin resistance [3]. The rapid increase in
prevalence of T2D is thought to be at least partly explained by the
change in environmental factors (nutrition and life style) acting on
genetically susceptible individuals, who may become obese and
consequently develop insulin resistance and T2D. This hypothesis
received support from the fact that several candidate genes known
for T2D, such as PPARG [4] and LPIN2 [5], are involved in the
development of fat tissue, while FTO [6] gene may be involved in
regulation of food intake.
Up until recently only few genes were unequivocally implicated
in risk of Type 2 Diabetes. In the last year, large progress has been
made through the genome-wide association studies. Besides
confirming the previously known T2D loci PPARG [4], TCF7L2
[7] and KCNJ11 [8], the GWA studies have identified new loci
CDKAL1, CDKN2A/CDKN2B, IGF2BP2, FTO, SLC30A8 and
HHEX [9–12] that influence the risk of T2D. A recently published
meta-analysis introduced yet another 6 loci associated with T2D,
JAZF1, CDC123-CAMK1D, TSPAN8-LGR5, THADA, ADAMTS9
and NOTCH2 [13].
We have selected polymorphisms in nine T2D genes, CDKAL1,
CDKN2A/CDKN2B, FTO, HHEX, IGF2BP2, KCNJ11, PPARG,
SLC30A8 and TCF7L2. Two of these genes, PPARG and KCNJ11,
are well-established candidate genes involved in T2D pathways,
while the other seven were discovered in initial GWAS and
therefore should explain a large fraction of T2D cases.
Results and Discussion
Association between the polymorphisms and the measures of
fatness was studied in ,3,000 participants from The Erasmus
Rucphen Family (ERF) study. The ERF study is a family based
study of a recent genetically isolated population located in the
South West of the Netherlands [14]. Participants that were
classified as diabetic, according to the use of anti-diabetic
medication (oral medication or insulin) or had fasting plasma
glucose levels $7.0 mmol/l, were excluded from the analyses
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mass index (FMI) and to fat percentage (FAT), as assessed by Dual
Energy X-ray Absorptimetry (DEXA), and to body mass index
(BMI), waist circumference (WC) and waist to hip ratio (WHR). In
total, 3035 participants had complete genotypic and phenotypic
information and were used in analysis. In this study, at nominal
p=0.05, we had 97% power to detect influence explaining as little
as 0.5% of the trait’s variation, 85% power to detect 0.3% of the
trait’s variation and 41% power to detect 0.01% of the trait’s
variation.
Characteristics of the population studied are presented in
Table 1 and SNPs details are presented in Table 2.
In our association study each SNP was individually tested for
association to each of the measures of fatness traits. There was
significant association between the risk allele of the FTO gene and
most of the measures of fatness traits. The significant association
was observed between rs8050136 and BMI p=0.003, FMI
p=0.007, WC p=0.03 and border line significance for FAT
p=0.053. The results of the individual SNP analyses are presented
in Table 3.
To estimate the combined effect of all risk alleles on the measure
of fatness traits, we computed the risk allelic score, estimated as the
number of T2D risk alleles in the genotype of an individual. The
mean allelic score was 9.44 (SD=1.88, range: 3–16). Though
effects of the score on every fatness trait were positive, there was no
evidence for significant association between the risk score and any
of the traits. The lowest, marginally nominally significant, p-values
were observed for the association of the risk allelic score with body
mass index (p=0.067) and waist circumstance (p=0.065). Results
of the analyses of the risk allelic score are presented in Table 4.
We analyzed the data stratified by disease status (type 2 diabetes
yes/no) and by sex. However, there was no evidence for
statistically significant association in these sub-sets. We also
performed an extreme analyzes on our data, assessing an
association between the measures of fatness and selected
population (10% top vs. 10% bottom levels of the population).
Comparing this two extreme groups we did not see escalations
from the previous results. The results of the extreme analyzes are
presented in Tables S1 and S2.
Our study is among the first to assess association between
recently discovered T2D loci and measures of fatness as
characterized with Dual Energy X-ray Absorptiometry (DEXA).
We found significant association between rs8050136 (FTO) and
BMI (p=0.003), FMI (p=0.007) and WC (p=0.03); fat percentage
was borderline significant (p=0.053). No other SNPs alone or
combined in a risk score demonstrated significant association to
the measures of fatness.
Table 1. General characteristics of the population studied.
Trait Women (N=1721) Men (N=1314)
Age – years 50.33615.95 49.97614.93
Height – cm 161.8766.48 174.9967.19*





FAT % 38.6467.58 26.7167.13*
WC-cm 81.32611.87 93.37611.44*
WHR 0.8060.08 0.9460.08*
All values are means or percentages6SD. BMI=body mass index, FMI=fat mass
index, FAT=fat percentage, WC=waist circumference, WHR=waist to hip ratio.
*=p,0.05.
doi:10.1371/journal.pone.0008541.t001
Table 2. T2D susceptible alleles and genotype frequencies for the ERF participants.
Locus Chr SNPs Position (bp) Alleles N Allele Freq. (n) Genotype Frequencies (n) Phw Freq. Ref.
A1/A2 A1 A2 A1A1 A1A2 A2A2
IGF2BP2 3 rs4402960 186994389 T/G 2891 28.8 71.2 8.8 40.1 51.1 0.238 0.29–0.30
(833) (2058) (253) (1159) (1479)
CDKN2B 9 rs10811661 22124094 T/C 2888 86.6 13.4 75.1 23 1.9 0.748 0.83–0.85
(2501) (387) (2168) 666 54
CDKAL1 6 rs7754840 20769229 C/G 2871 32.7 67.3 11.4 43.3 45.3 0.127 0.31–0.36
(993) (2115) (326) (1229) (1316)
PPARG 3 rs1801282 12368125 C/G 2955 90.1 9.9 81.3 17.7 1 0.757 0.82–0.86
(2662) (293) (2402) (523) (30)
SLC30A8 8 rs13266634 118253964 C/T 2934 69.2 30.8 47.4 43.6 9 0.260 0.61–0.75
(2030) (904) (1391) (1278) (265)
HHEX 10 rs1111875 94452862 C/T 2940 59.2 40.8 34.9 48.4 16.7 0.939 0.52–0.64
(1740) (1200) (1028) (1423) (489)
KCNJ11 11 rs5219 17366148 T/C 2935 33.6 66.4 11.4 44.4 44.2 0.804 0.46–0.47
(986) (1949) (335) (1304) (1296)
TCF7L2 10 rs7903146 114748339 T/C 2916 28.5 71.5 7.8 41.3 50.9 0.467 0.18–0.26
(831) (2084) (228) (1204) (1482)
FTO 16 rs8050136 52373776 A/C 2942 43.1 56.9 17.2 51.8 31.0 0.011 0.38
(1268) (1674) (505) (1524) (913)
Chr.=Chromosome, Risk allele for type 2 diabetes underlined. Phw=p value for hardy-weinberg. Freq. Ref.=reference frequency.
doi:10.1371/journal.pone.0008541.t002
T2D Associated with Obesity
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fatness may be at least partly explained because some of these were
discovered using cohorts of lean subjects. This especially concerns
loci discovered in the study of Sladek et al. [9] where discovery
stage was based on lean participants with young onset. Later, it
was shown that SLC30A8 exhibited its effect mostly in the lean
participants [15]. However, the loci such as TCF7L2, HHEX,
PPARG, FTO, KCNJ11, CDKN2B, IGNF2BP2, and CDKAL1, were
discovered in GWAS [10–13] where cases were not selected for
BMI.
In agreement with other studies [16] we found no association
between PPARG and the measures of fatness. However, the variant
of PPARG (rs1801282) shows some controversy in the associations
with obesity. Even though the variant has been replicated many
times as a risk one for type 2 diabetes and severe insulin resistance
[4], its effect on BMI is unclear. Some studies showed that
Pro12Ala allele, associated with T2D, is associated with lower
body mass index [17], but other studies showed that the same
polymorphism is not associated with childhood or adult obesity
[16]. Despite this controversy, the biological role of PPARG in the
fat cell differentiation and lipodistrophy is strongly proven. Cauchi
et al. [15] recently suggested that the effect of genetic polymor-
phisms, including PPARG, which have a role in adipocyte
differentiation, maturation and action, and lead to insulin
resistance, might be worsened by the effect of obesity.
In this study we also confirm an association between the FTO
gene and measures of fatness. Even thou the FTO gene was first
discovered as T2D gene in an analysis not adjusted for BMI; after
Table 3. Individual effects of T2D polymorphisms.
SNP Locus Risk Alle. Freq. TRAIT
BMI FMI FAT WC WHR
b Se p b se p b se p b se p b se p
rs13266634 C 0.69 20.18 0.14 0.28 20.1 0.1 0.43 20.09 0.23 0.76 20.13 0.34 0.68 21.33E-03 2.07E-03 0.59
SLC30A8
rs10811661 T 0.87 20.04 0.18 0.87 20.02 0.14 0.92 20.01 0.3 0.99 0.06 0.46 0.91 2.02E-03 2.78E-03 0.54
CDKN2AB
rs7754840 C 0.33 0.15 0.13 0.35 0.08 0.1 0.5 0.17 0.22 0.52 0.2 0.33 0.61 24.29E-04 2.00E-03 0.86
CDKAL1
rs4402960 T 0.29 0.17 0.14 0.29 0.07 0.1 0.56 20.06 0.22 0.83 0.35 0.33 0.38 8.09E-04 2.05E-03 0.74
IGF2BP2
rs1111875 C 0.59 0.11 0.13 0.47 0.06 0.09 0.58 0.16 0.21 0.53 0.14 0.31 0.71 6.92E-04 1.91E-03 0.76
HHEX
rs1801282 C 0.9 0.25 0.22 0.31 0.22 0.16 0.24 0.65 0.35 0.13 0.38 0.52 0.53 28.17E-05 3.17E-03 0.98
PPARG
rs5219 T 0.34 20.04 0.13 0.81 2.1E-03 0.1 0.99 0.13 0.22 0.64 0.16 0.33 0.68 1.67E-03 1.99E-03 0.48
KCNJ11
rs7903146 T 0.28 0.1 0.14 0.56 0.08 0.1 0.5 0.28 0.23 0.33 0.39 0.34 0.34 2.32E-03 2.09E-03 0.35
TCF7L2
rs8050136 A 0.43 0.45 0.13 3.0E-03* 0.31 0.09 7.0E-03* 0.51 0.21 5.3E-02 0.79 0.32 3.0E-02* 1.02E-03 1.96E-03 0.66
FTO
All analyses are adjusted for sex and age. BMI=body mass index, FMI=fat mass index, FAT=fat %, WC=waist circumference, WHR=waist to hip ratio. b=beta
coefficient, se=standard error, p=p value, *=p,0.05.
doi:10.1371/journal.pone.0008541.t003
Table 4. Effects of the risk allelic score on traits.
Traits Intercept6se Sex Age Score
bs6se ps ba6se pa b6se p
BMI 22.2560.60 0.7960.20 6.65E-05 0.0660.01 ,2E-16 0.1260.05 0.067
FMI 7.5460.44 22.8260.15 ,2E-16 0.0460.01 1.15E-12 0.0860.04 0.086
FAT 33.7560.98 211.7760.32 ,2E-16 0.0660.01 4.71E-08 0.2060.09 0.065
WC 65.1961.46 12.2660.48 ,2E-16 0.2860.02 ,2E-16 0.2760.13 0.081
WHR 0.6660.01 0.1462.9E-03 ,2E-16 2.9E-0361.0E-04 ,2E-16 8.8E-0467.7E-04 0.336
bs=coefficient for sex, ba=coefficient for age, b=coefficient for risk allelic score, pi=p-value for intercept, ps=p=value for sex, pa=p-value for age, p=p-value for
measure of fatness traits.
doi:10.1371/journal.pone.0008541.t004
T2D Associated with Obesity
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the effect of FTO on BMI [18]. Another gene which may be
involved in fat tissue development and T2D is the LPIN2 gene [5],
which is the human homologues of mouse gene Lpin1 involved also
in the human lipodistrophy.
To conclude, though FTO locus provides a strong example of
T2D locus with an effect on measures of fatness, in general the
direct effects of T2D loci on measures of fatness are limited.
Materials and Methods
Study Population
Subjects were participants of the Erasmus Ruchpen Family
(ERF) study. The Erasmus Ruchpen Family (ERF) study is a
family based study of a genetically isolated population located in
the South West of the Netherlands. The population was founded
in the middle of the 18
th century by less than 400 people and
experienced exponential growth and minimal immigration during
the last decades. Currently, the population consists of more than
20,000 inhabitants scattered across eight adjacent villages. For the
ERF study, with the help of genealogical records, twenty couples
that had at least 6 children baptized in the community church
between 1850–1900 were identified. All living descendants of these
couples and their spouses were invited to participate in the study.
The present study is based on ,3,000 participants. All
participants gave an informed written consent, and the Medical
Ethical Committee of the Erasmus Medical Center Rotterdam,
approved the study protocol.
Data Collection
All participants of the ERF study were invited for extensive
clinical examinations at the research center. Fasting blood
samples, anthropometric measurements and personal interviews
were obtained with medical practitioners.
For the current study measures of fatness and anthropometric
measurements were used. Height and weight were measured with
the participants dressed in light underclothing. Fat mass and lean
mass were assessed using Dual Energy X-ray Absorptiometry
(DEXA). Body mass index (BMI) was calculated as weight divided
by height squared (kg/m
2). Accordingly, FMI was calculated as fat
mass divided by height squared (kg/m
2) and LMI as lean mass
divided by height squared.
Genotyping
We genotyped the following SNPs in all participants: rs7754840
(CDKAL1), rs10811661 (CDKN2AB), rs8050136 (FTO), rs1111875
(HHEX), rs4402960 (IGF2BP2), 5215 (KCNJ11), rs1801282
(PPARG), rs13266634 (SLC30A8) and rs7903146 (TCF7L2). The
genotyping was performed using TaqMan allelic discrimination
Assays-By-Design (Applied Biosystems, Foster City, CA, http://
store.appliedbiosustems.com). Genotypes were determined in 2-ng
genomic DNA. Reactions were performed on the TaqMan Prism
7900HT platform.
Statistical Analyses
All statistical analyses were performed using statistical package
R (www.r-project.org). Prior to analyses a quality control was
performed on all SNPs, assessing a minor allele frequency
(all.0.05), call rate (all.0.94) and Hardy-Weinberg Equilibrium
(Tab. 2), and presence of duplicates. The association analyses were
done using GenABEL package [18] for R. SNPs were individually
tested for association with BMI, FMI, fat percentage, waist
circumference and waist to hip ratio using the linear regression
model, adjusted for sex and age. The p-values were corrected by
the inflation factor using genomic control method [19]. The results
were not corrected for multiple testing. To estimate the combined
effect of all risk alleles, the risk allelic score was calculated as total
number of risk alleles (alleles associated with increase T2D) present
in the genotype of the study participant. The linear regression
model, adjusted for sex and age, was applied to estimate the
association of the risk allelic score on the five measures of fatness.
Supporting Information
Table S1 Individual effects of T2D polymorphisms on selected
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